Loading…
Terumo Corporation announced on November 20, 2019, that it has decided to acquire Aortica Corporation, a U.S.-based company developing personalized vascular therapy technology including AortaFit software and BoulEVARd stent graft.
“This acquisition is a tremendous opportunity for Terumo Aortic to expedite the development of a first-in-class, purpose-built FEVAR System.”terumo.com
Summarized from public sources; check the original articles before acting on it.